Post-acne scars: what a specialist should know about scarring of the skin. A review
- Authors: Karapetyan M.M.1, Dvoriankova E.V.2, Korsunskaya I.M.1,2
-
Affiliations:
- Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology
- Center for Theoretical Problems of Physicochemical Pharmacology
- Issue: Vol 27, No 6 (2025): DERMATOLOGY and ALLERGOLOGY
- Pages: 352-355
- Section: Articles
- URL: https://bakhtiniada.ru/2075-1753/article/view/309790
- DOI: https://doi.org/10.26442/20751753.2025.6.203239
- ID: 309790
Cite item
Full Text
Abstract
Acne is a relatively common dermatological problem in adolescents and adults. Acne may resolve, leaving post-inflammatory erythema, depigmentation, and scarring. Scars often cause low self-esteem, depression, and anxiety. Skin damage caused by acne triggers a cascade of reactions aimed at wound healing, including three stages: inflammation, formation of granulation tissue, and matrix remodeling. An imbalance of matrix metalloproteases and their tissue inhibitors at the last stage leads to atrophic or hypertrophic scars. The atrophic scars are characterized by the loss of collagen during wound healing: 80–90% of patients with post-acne scarring develop atrophic scars, which are divided into three types. The most common are "axe scars," followed by rolling scars, and "freight car" scars are less common. However, it should be noted that all three types of scars can form in the same subject. The formation of hypertrophic and keloid scars is associated with excessive collagen deposition due to decreased collagenase activity. These types of scars mainly occur in people with darker skin color and are predominantly localized on the trunk. The most effective way to control post-acne scars is through prevention with proper acne treatment. A wide range of tools is used to treat existing scars, from chemical peels to laser correction, but combined methods show better results.
Full Text
##article.viewOnOriginalSite##About the authors
Mari M. Karapetyan
Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology
Email: marykor@bk.ru
ORCID iD: 0000-0002-4862-2779
dermatologist
Russian Federation, MoscowEvgeniya V. Dvoriankova
Center for Theoretical Problems of Physicochemical Pharmacology
Email: marykor@bk.ru
ORCID iD: 0000-0002-2458-419X
D. Sci. (Med.)
Russian Federation, MoscowIrina M. Korsunskaya
Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology; Center for Theoretical Problems of Physicochemical Pharmacology
Author for correspondence.
Email: marykor@bk.ru
ORCID iD: 0000-0002-6583-0318
D. Sci. (Med.), Prof.
Russian Federation, Moscow; MoscowReferences
- Fabbrocini G, Annunziata MC, D’Arco V, et al. Acne scars: pathogenesis, classification and treatment. Dermatol Res Pract. 2010;2010:893080. doi: 10.1155/2010/893080
- Дворянкова Е.В. Роль диеты в патогенезе акне у взрослых. Дерматология. Consilium Medicum. 2017;3:12-5 [Dvoryankova EV. The role of diet in the pathogenesis of adult acne. Dermatology. Consilium Medicum. 2017;3:12-5 (in Russian)].
- Goulden V, Stables GI, Cunliffe WJ. Prevalence of facial acne in adults. J Am Acad Dermatol. 1999;41:577–80. PMID: 10495379
- Fife D. Practical evaluation and management of atrophic acne scars: Tips for the general dermatologist. J Clin Aesthet Dermatol. 2011;4(8):50-7. PMID: 21909457
- Tan J, Beissert S, Cook-Bolden F, et al. Impact of facial atrophic acne scars on quality of life: A multi-country population-based survey. Am J Clin Dermatol. 2022;23(1):115-23. doi: 10.1007/s40257-021-00628-1
- Hazarika N. Acne vulgaris: New evidence in pathogenesis and future modalities of treatment. J Dermatolog Treat. 2021;32(3):277-85. doi: 10.1080/09546634.2019.1654075
- Alestas T, Ganceviciene R, Fimmel S, et al. Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J Mol Med (Berl). 2006;84(1):75-87. doi: 10.1007/s00109-005-0715-8
- Dréno B, Dagnelie MA, Khammari A, Corvec S. The skin microbiome: A new actor in inflammatory acne. Am J Clin Dermatol. 2020;21(Suppl. 1):18-24. doi: 10.1007/s40257-020-00531-1
- Kim J, Ochoа M-T, Krutzik SR, et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol. 2002;169(3):1535-41. doi: 10.4049/jimmunol.169.3.1535
- Wolfram D, Tzankov A, Pülzl P, Piza-Katzer H. Hypertrophic scars and keloids – A review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg. 2009;35(2):171-81. doi: 10.1111/j.1524-4725.2008.34406.x
- Martin P, Leibovich SJ. Inflammatory cells during wound repair: The good, the bad and the ugly. Trends Cell Biol. 2005;15(11):599-607. doi: 10.1016/j.tcb.2005.09.002
- Holland DB, Jeremy AHT, Roberts SG, et al. Inflammation in acne scarring: A comparison of the responses in lesions from patients prone and not prone to scar. Br J Dermatol. 2004;150(1):72-81. doi: 10.1111/j.1365-2133.2004.05749.x
- Baum CL, Arpey CJ. Normal cutaneous wound healing: Clinical correlation with cellular and molecular events. Dermatol Surg. 2005;31(6):674-86; discussion 686. doi: 10.1111/j.1524-4725.2005.31612
- Chivot M, Pawin H, Beylot C, et al. Acne scars: Epidemiology, physiopathology, clinical features and treatment. Ann Dermatol Venereol. 2006;133(10):813-24 (in French). doi: 10.1016/s0151-9638(06)71053-5
- Jfri A, Alajmi A, Alazemi M, Ladha MA. Acne scars: An update on management. Skin Therapy Lett. 2022;27(6):6-9. PMID: 36469561
- Goodman GJ, Baron JA. Postacne scarring: A qualitative global scarring grading system. Dermatol Surg. 2006;32(12):1458-66. doi: 10.1111/j.1524-4725.2006.32354.x
- Dreno B, Khammari A, Orain N, et al. ECCA grading scale: An original validated acne scar grading scale for clinical practice in dermatology. Dermatology. 2006; 214(1):46-51. doi: 10.1159/000096912
Supplementary files
